Use of Endocrine Therapy for Breast Cancer Risk Reduction Guidelines Pocket Guide - Guideline Central

Use of Endocrine Therapy for Breast Cancer Risk Reduction

American Society of Clinical OncologyPublished: September 3, 2019

A PDF version of this Pocket Guide is also available!
$9.95
  • Key Points
  • Tables
    • Breast Cancer Risk Assessment Tools
    • Summary of All Recommendations
    • Summary of Agent Indications
    • Adverse Effects of Endocrine Therapy


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.